Kiadis Pharma NV (KDS) - Financial and Strategic SWOT Analysis Review

  • ID: 4281512
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Kiadis Pharma
1 of 4
Summary

Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that researches, develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 offers risks and limitations in blood cancers, cancer relapse, opportunistic infections, and limited donor availability. Kiadis develops ATIR201 for the treatment of thalassemia. The company uses Theralux platform, to develop therapeutic products. Its products serve the needs of patients suffering from hematological malignancies and blood cancer transplant. Kiadis is headquartered in Amsterdam, the Netherlands.

Kiadis Pharma NV Key Recent Developments

Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day
Jan 16, 2018: Kiadis Pharma proposes former Cipla CEO Subhanu Saxena as new Supervisory Board member
Dec 06, 2017: Kiadis Pharma to lease existing commercial manufacturing facility in The Netherlands
Sep 29, 2017: Kiadis Pharma appoints Dr. Andrew Sandler as Chief Medical Officer
Sep 29, 2017: Kiadis Pharma appoints Dr. Andrew Sandler as Chief Medical Officer

This comprehensive SWOT profile of Kiadis Pharma NV provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kiadis Pharma NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Kiadis Pharma NV - Key Information
  • Kiadis Pharma NV - Overview
  • Kiadis Pharma NV - Key Employees
  • Kiadis Pharma NV - Key Employee Biographies
  • Kiadis Pharma NV - Key Operational Heads
  • Kiadis Pharma NV - Major Products and Services
  • Kiadis Pharma NV - History
  • Kiadis Pharma NV - Company Statement
  • Kiadis Pharma NV - Locations And Subsidiaries
  • Kiadis Pharma NV - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Kiadis Pharma NV - Business Description
  • Kiadis Pharma NV - Corporate Strategy
  • Kiadis Pharma NV - SWOT Analysis
  • SWOT Analysis - Overview
  • Kiadis Pharma NV - Strengths
  • Kiadis Pharma NV - Weaknesses
  • Kiadis Pharma NV - Opportunities
  • Kiadis Pharma NV - Threats
  • Kiadis Pharma NV - Key Competitors
Section 3 - Company Financial Performance Charts
  • Kiadis Pharma NV - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Kiadis Pharma NV, Key Information
  • Kiadis Pharma NV, Key Ratios
  • Kiadis Pharma NV, Share Data
  • Kiadis Pharma NV, Major Products and Services
  • Kiadis Pharma NV, History
  • Kiadis Pharma NV, Key Employees
  • Kiadis Pharma NV, Key Employee Biographies
  • Kiadis Pharma NV, Key Operational Heads
  • Kiadis Pharma NV, Other Locations
  • Kiadis Pharma NV, Subsidiaries
  • Kiadis Pharma NV, Key Manufacturing facilities
  • Kiadis Pharma NV, Key Competitors
  • Kiadis Pharma NV, SWOT Analysis
  • Kiadis Pharma NV, Ratios based on current share price
  • Kiadis Pharma NV, Annual Ratios
  • Kiadis Pharma NV, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Kiadis Pharma NV, Performance Chart
  • Kiadis Pharma NV, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll